Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

2013 GuidanceGenVec's Senior Vice President and Chief Financial Officer, Douglas J. Swirsky , commented, "For 2013, we anticipate our cash burn will be between $8.0 million and $9.0 million."

Conference Call InformationGenVec will hold a conference call today at 10:00 a.m. EDT to discuss the Company's financial results and 2013 business outlook.  To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 17801867.  An audio replay of the conference call will be available starting at 1:00 p.m. EDT on March 22, 2013 through March 29, 2013.  To listen to the audio replay, dial 855-859-2056 or 404-537-3406 (international) and use access code 17801867.

A live webcast of the conference call will be available on the Company's website and will be archived for 30 days.  To access the webcast or the replay, go to www.genvec.com, and click on "Investors and Media".

About GenVecGenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD). Addit
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3,  2015 About artificial ... devices, which are implanted or integrated into ... These include artificial heart, kidney, pancreas, and ... (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, ... organs. These organs are incorporated with different ...
(Date:9/3/2015)... 3, 2015 This Defibrillators are critical life ... of lives across globe. This report provides in-depth analysis ... Saudi Arabia . Stakeholders for this report include ... and regulatory bodies. The Saudi Arabia ... by products and by end users. In terms of ...
(Date:9/3/2015)... 3, 2015 Nevro Corp. (NYSE: NVRO ... innovative evidence-based solutions for the treatment of chronic pain, ... the Morgan Stanley Global Healthcare Conference on Thursday, September ... Nevro management is scheduled to present at 11:45 a.m. ... audio webcast, accessible in the "Investors" section of the ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... LAGUNA HILLS, Calif., Sept. 30 Minnow Medical, Inc., ... thermoplasty for the treatment of in-stent restenosis and other ... executive Raymond W. Cohen has been named chief executive ... Cohen, 51, has more than 25 ...
... Ohio, Sept. 30 Although last year,s flu season ... illness and associated vaccine shortages, pharmacy experts at Cardinal ... for the 2010-2011 flu season. The upcoming ... federal government,s Advisory Committee on Immunization Practices (ACIP) has ...
Cached Medicine Technology:Minnow Medical Names Raymond W. Cohen as Chief Executive Officer 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 3Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 4
(Date:9/4/2015)... , ... September 04, 2015 , ... Keeping mold top ... around the home is quite common. Mold can grow anywhere - on carpet, clothing, ... pipes. Checking for excessive moisture and water in the home is key to preventing ...
(Date:9/4/2015)... ... ... are looking for a quick and convenient way to produce a hot remedy for colds. ... a quick and simple way to brew a hot cup of cold remedy when desired. ... they enhance comfort and health. The invention features a novel design that is lightweight, compact ...
(Date:9/4/2015)... ... 2015 , ... Having access to a doctor can sometimes be a challenge ... unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to those ... solution to alleviate this problem has recently presented itself, the new telemedicine platform and ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers ... settlements under the Stark physician self-referral law. “Stark Law DOs and DON’Ts: ... Atlantic Information Services, Inc. (AIS), will detail which deals are attracting the most ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Friday night, Chicago ... hosting Generation Rescue’s A Night of Hope event supporting families affected by autism, raising ... Rowena and Joe Salas, joined together at the Oscar Swan Inn to support the ...
Breaking Medicine News(10 mins):Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... From arugula leaves that have a crunch and a peppery ... markets is finding its way into the most divine salad ... coloured bell peppers are becoming hot favourites for toss-it-up-your-way spreads. ... that greens offer a wave of flavours for every palate. ...
... hysterectomy and laparoscopically assisted vaginal hysterectomy could probably ... of lower morbidity // and faster recovery, very ... although there is a high feasibility rate. Vaginal ... to be familiar with surgical techniques. Many surgeons ...
... they impact upon the foods we eat, the products we ... with whom we spend time // . Evaluation of stimulus ... the brain uses it as a basic category for organizing ... also thought to be immediate, unintentional and linked to behavioral ...
... found to have a higher risk of developing breast cancer ... same, a new research has concluded. //, ,Hodgkin's is ... immune system organs. Researchers found that women had a 40 ... Hodgkin's lymphoma. Dr Lois B. Travis, from the National Cancer ...
... monoclonal antibodies (mAbs) are fare more likely to be ... a study completed by // consultancy Propagate Pharma, about ... profitable. That means mAbs are recouping more in revenues ... of development and marketing. By comparison, the study estimates ...
... increased risk of HIV during pregnancy because of ... because of the physiological changes during gestation. Irrespective ... that rates of HIV acquisition are significantly higher ... important implications for HIV prevention, both to protect ...
Cached Medicine News:Health News:Conditioning preferences in children 2Health News:Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs 2Health News:Women might be at increased risk of HIV during pregnancy 2
A handy quick-reference tool for busy residents and clinicians with key facts and points essential for day-to-day patient care....
Nursing2006 Drug Handbook Entries include Alerts, dosage adjustments for specific populations, I.V. administration, off-label indications, adverse reactions, and more....
... Nurse's Pocket Drug Guide 2005 includes over ... data relating to their selection and administration. ... each drug includes key data featuring common ... nursing implications and patient education information. A ...
The mission of AHFS DI Essentials (American Hospital Formulary Service) is to provide an evidence-based foundation for safe and effective drug therapy....
Medicine Products: